Fasting among Muslim cancer patients during the holy month of Ramadan.

Annals of Saudi Medicine
Ahmed Abdelmabood Zeeneldin, Fatma Mohamed Taha

Abstract

Muslims constitute more than 20% of the world's population and have a significant share of its cancer cases. Many Muslim cancer patients witness the fasting month of Ramadan but we do not know which individuals elect to fast. Cross-sectional study conducted among Muslim cancer patients at the National Cancer Institute (NCI), Egypt, during Ramadan, Hijri 1430 (the month of fasting) August-September 2009. One-hundred and two patients being treated at the NCI were interviewed. The most common diagnoses were breast cancer (31%), acute leukemia (24%), colorectal cancer (7%), non-Hodgkin lymphoma (5%), bladder cancer (4%), lung cancer (4%), and laryngeal cancer (4%). The two sexes were equally represented and so were metastatic and nonmetastatic diseases. The outpatient:inpatient ratio was 3:1. Treatments being received by these patients included chemotherapy, radiotherapy, hormonal therapy, and nonspecific therapy in 42%, 31%, 10%, and 17%, respectively. Other concomitant diseases were present in 22% of the patients. While 40% of patients did not fast at all during Ramadan, 36% and 24% were partial and complete fasters, respectively. Female patients, those with performance status (PS) 0 to 1, those whose disease was a nonmetastatic ...Continue Reading

Citations

Mar 13, 2014·BMC Health Services Research·Kerry WilburEman Remoden
Feb 24, 2016·Frontiers in Oncology·Nicola Luigi BragazziMohamed Zouhir
May 29, 2014·Japanese Journal of Clinical Oncology·Faruk TasRian Disci
Sep 6, 2019·Journal of Religion and Health·Mohamed Ezzat Khamis AminMarwa J Farhat
May 20, 2019·Journal of Religion and Health·Mohamed Ezzat Khamis Amin, Ahmed Abdelmageed
Mar 27, 2015·Annals of Saudi Medicine·Ahmed Zeeneldin
Aug 20, 2021·Oncology Nursing Forum·Fawwaz AlaloulMichael A Andrykowski

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.